Oruka reports psoriasis trial results
Oruka Therapeutics (NASDAQ:ORKA) reported positive Week 28 results from the Phase 2a EVERLAST-A trial evaluating ORKA-001 in patients with moderate-to-severe plaque psoriasis.
Oruka Therapeutics (NASDAQ:ORKA) reported positive Week 28 results from the Phase 2a EVERLAST-A trial evaluating ORKA-001 in patients with moderate-to-severe plaque psoriasis.
AC Immune (NASDAQ:ACIU) reported that all primary endpoints were met at week 100 in Part 1 of its Phase 2 VacSYn trial evaluating ACI-7104 in early Parkinson’s disease.
Sharon AI (NASDAQ:SHAZ) is collaborating with VAST Data to offer VAST DataEnclave confidential AI capabilities through its AI Factory platform across Australia and Asia-Pacific.
Cintas (NASDAQ:CTAS) reported fiscal 2027 first-quarter revenue of $3.01 billion, an increase of 10.9% from $2.72 billion in the prior-year period.
Viasat (NASDAQ:VSAT) secured a $42 million initial task order under a seven-year U.S. Marine Corps satellite communications contract announced on September 23, 2026.
SLB (NYSE:SLB) received a contract from OQ Exploration & Production (OQEP) to deliver the Bisat-B Expansion Production Facility in Oman.
HUHUTECH (NASDAQ:HUHU) reported first-half 2026 revenue of $10.67 million, an increase of 8.6% from the prior-year period, supported by contributions from new international operations.
Roivant (NASDAQ:ROIV) reported topline results from Immunovant’s proof-of-concept trial of IMVT-1402 in cutaneous lupus erythematosus, with the study failing to meet its primary endpoint.
IM Cannabis (NASDAQ:IMCC) signed a non-binding letter of intent to acquire 51% of Space Defense Innovations (SDI), a Poland-based company operating in the European unmanned aerial systems market.
Best Buy (NYSE:BBY) and Amazon (NASDAQ:AMZN) expanded their multiyear Fire TV partnership to continue providing Fire TV software on Insignia TVs and introduce new connected TV advertising opportunities.
GARANTA JÁ SEU GRAFA EDGE
Vamos ativar um teste de 30 dias do Edge como presente de boas-vindas
Tem um segundo para um cookie? 🍪Os cookies essenciais mantêm a Grafa funcionando bem. Alguns opcionais nos ajudam a ver o que está funcionando para melhorarmos. Você tem o controle — pode mudar de ideia quando quiser. Política de cookies · Política de privacidade